Literature DB >> 2712443

Impairment after adult respiratory distress syndrome. An evaluation based on American Thoracic Society recommendations.

A J Ghio1, C G Elliott, R O Crapo, S L Berlin, R L Jensen.   

Abstract

To test the hypothesis that impairment after the adult respiratory distress syndrome (ARDS) is uncommon, we evaluated 41 ARDS survivors using ATS standards for determination of impairment. A total of 101 trials of pulmonary function tests were obtained between 1 and 388 wk after the onset of ARDS. It was possible to evaluate impairment at 1 yr or more after ARDS in 27 subjects. Eighteen of the 27 were impaired. The percentage of ARDS survivors who were impaired on the basis of FVC, FEV1, FEV1/FVC, and DLCOsb was 50.0, 61.1, 33.3, and 82.4%, respectively. Impairment was mild in 13 (72.2%), moderate in four (22.2%), and severe in one (5.6%). Smoking status had no predictive value in determining impairment. Physiologic indices of ARDS severity (maximal pulmonary artery pressure, lowest static thoracic compliance, and maximal level of PEEP) were found to be significantly different when those impaired 1 yr or more after ARDS were compared with those not impaired. Symptoms were found to have no association with impairment. We conclude that, using ATS criteria, impairment 1 yr or more after ARDS onset is common. Patient characteristics and symptoms after ARDS have no association with impairment 1 yr or more after ARDS onset, whereas physiologic indices of severity during ARDS do.

Entities:  

Mesh:

Year:  1989        PMID: 2712443     DOI: 10.1164/ajrccm/139.5.1158

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  13 in total

Review 1.  The pulmonary physician and critical care. 2. The injured lung: conventional and novel respiratory therapy.

Authors:  A Swami; B F Keogh
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

2.  Expanding our horizons beyond the intensive care unit: does mechanism of lung injury influence the quality of life in ARDS survivors?

Authors:  Salvatore Maurizio Maggiore; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2006-09-07       Impact factor: 17.440

3.  Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.

Authors:  G Aisenberg; K V Rolston; B F Dickey; D P Kontoyiannis; I I Raad; A Safdar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-01       Impact factor: 3.267

Review 4.  Acute respiratory distress syndrome.

Authors:  Satyendra Sharma
Journal:  BMJ Clin Evid       Date:  2007-05-01

5.  Inflammation-induced caveolin-1 and BMPRII depletion promotes endothelial dysfunction and TGF-β-driven pulmonary vascular remodeling.

Authors:  Suellen D S Oliveira; Maricela Castellon; Jiwang Chen; Marcelo G Bonini; Xiaowu Gu; Michael H Elliott; Roberto F Machado; Richard D Minshall
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-10       Impact factor: 5.464

6.  Long-term outcomes in survivors of acute respiratory distress syndrome ventilated in supine or prone position.

Authors:  D Chiumello; P Taccone; V Berto; A Marino; G Migliara; M Lazzerini; L Gattinoni
Journal:  Intensive Care Med       Date:  2011-12-21       Impact factor: 17.440

Review 7.  Acute respiratory distress syndrome.

Authors:  Sat Sharma
Journal:  BMJ Clin Evid       Date:  2010-11-30

Review 8.  Long-Term Outcomes in Acute Respiratory Distress Syndrome: Epidemiology, Mechanisms, and Patient Evaluation.

Authors:  Jessica A Palakshappa; Jennifer T W Krall; Lanazha T Belfield; D Clark Files
Journal:  Crit Care Clin       Date:  2021-05-27       Impact factor: 3.879

Review 9.  Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers.

Authors:  Margaret S Herridge; Marc Moss; Catherine L Hough; Ramona O Hopkins; Todd W Rice; O Joseph Bienvenu; Elie Azoulay
Journal:  Intensive Care Med       Date:  2016-03-30       Impact factor: 17.440

Review 10.  Clinical review: Intensive care follow-up--what has it told us?

Authors:  L Robert Broomhead; Stephen J Brett
Journal:  Crit Care       Date:  2002-08-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.